12:20

AI x Bio Pitch Contest — Ambitious Bio

Lizzy Hudson presents Ambitious Bio's human-tissue molecular data resource and answers questions about its scale and economics.

Xin

Chapters

  1. 00:00 The molecular bill of materials
  2. 01:45 Sourcing tissue and using AI
  3. 02:57 Proteomics and the data resource
  4. 05:06 Sample collection and scale
  5. 07:00 Q&A: How the resource compares
  6. 10:14 Q&A: Specimen costs and economics
Summary

Ambitious Bio founder and CEO Lizzy Hudson explains how the company collects donated human tissue and profiles samples to build a molecular reference for research. She focuses on proteomics, sourcing and analysis, and how customers use the resulting data. The judges ask how the resource compares with other data sources and what specimen costs mean for its model. Ambitious Bio received the contest's Audience Favorite award.

Watch next

More from the studio

TechCrunch Disrupt 2026 · AIEEV3:12Open Mic

TechCrunch Disrupt 2026 · AIEEV

AIEEV co-founder Hyeonkyeong (Karen) Kim explains the approach behind Air Cloud: connecting edge GPU devices for AI inference, supporting container-based deployment and autoscaling, and addressing hardware and network security. Recorded at TechCrunch Disrupt 2026.

Oct 22, 2026
AI x Bio Pitch Contest1:10

AI x Bio Pitch Contest

A short look at the September 29 AI x Bio Pitch Contest in San Francisco, from company pitches to the award presentations.

Oct 5, 2026
AI x Bio Pitch Contest — Optagon Labs9:25

AI x Bio Pitch Contest — Optagon Labs

Khalil Kaddoura presents Optagon Labs' proposed AI-driven loop for drug optimization and lab testing.

Oct 5, 2026